Ocronosis: reporte de caso y revisión de la literatura

Guido Alfonso Fierro; Juan Carlos González

doi:10.1016/j.rccot.2015.04.005

Autores/as

Guido Alfonso Fierro Hospital Occidente de Kennedy. Bogotá, Colombia
Juan Carlos González Fundación Santa Fe de Bogotá. Bogotá, Colombia

DOI:

https://doi.org/10.1016/j.rccot.2015.04.005

Palabras clave:

alcaptonuria, ocronosis, osteoartritis/diagnóstico, diagnóstico diferencial, hombro/ocronosis, revisión de la literatura, reportes de caso

Resumen

La manifestación musculoesquelética de la alcaptonuria es conocida como ocronosis, una enfermedad de baja prevalencia del metabolismo del ácido homogentísico. Se presenta el caso y el tratamiento ofrecido a una mujer de 56 años que mostró artropatía ocronótica con manifestación en hombros y rodillas. Además, se intenta sintetizar la fisiopatología, los hallazgos clínicos y patológicos de esta enfermedad, así como sus alternativas de manejo. Este caso merece ser reportado puesto que hay muy pocos pacientes diagnosticados con esta enfermedad y escasas imágenes intraarticulares del hombro afectado, debido a su baja prevalencia y a la alta de sospecha clínica requerida para realizar su oportuno diagnóstico.
Nivel de evidencia: IV

Descargas

Los datos de descargas todavía no están disponibles.

Biografía del autor/a

Guido Alfonso Fierro, Hospital Occidente de Kennedy. Bogotá, Colombia

Ortopedista y traumatólogo. Hospital Occidente de Kennedy, Bogotá, Colombia.

Juan Carlos González, Fundación Santa Fe de Bogotá. Bogotá, Colombia

Ortopedista y traumatólogo, magíster en epidemiología. Jefe del servicio de ortopedia y traumatología, Fundación Santa Fe de Bogotá, Bogotá, Colombia.

Referencias bibliográficas

Fisher AA, Davis MW. Alkaptonuric ochronosis with aortic valve and joint replacements and femoral fracture: a case report and literature review. Clin Med Res. 2004;2(4):209-15. https://doi.org/10.3121/cmr.2.4.209

Drakoulakis E, Varvitsiotis D, Psareas G, Feroussis J. Ochronotic arthropathy: diagnosis and management--a critical review. Am J Orthop. 2012;41(2):80-3.

Stenn FF, Milgram JW, Lee SL, Weigand RJ, Veis A. Biochemical identification of homogentisic acid pigment in an ochronotic egyptian mummy. Science. 1977;197:566-8. https://doi.org/10.1126/science.327549

Lee SL, Stenn FF. Characterization of mummy bone ochronotic pigment. J Am Med Assoc. 1978;240:136-8. https://doi.org/10.1001/jama.1978.03290020058024

Gaines JJ Jr. The pathology of alkaptonuric ochronosis. Hum. 1989;20:40-6. https://doi.org/10.1016/0046-8177(89)90200-1

Mannoni A, Selvi E, Lorenzini S, Giorgi M, Airo P, Cammelli D, et al. Alkaptonuria, ochronosis, and ochronotic arthropathy. Semin Arthritis Rheum. 2004;33(4):239-48. https://doi.org/10.1053/S0049-0172(03)00080-5

La Du BN, Zannoni VG, Laster L, Seegmiller JE. The nature of the defect in tyrosine metabolism in alkaptonuria. J Biol Chem. 1958;230:251-60. https://doi.org/10.1016/S0021-9258(18)70560-7

Milch RA. Studies of alkaptonuria: Inheritance of 47 genes in highly inter-related Dominican kindreds. Am J Hum Genet. 1960;12:76-85.

Srsen S, Cisarik F, Pasztor L, Harmecko L. Alkaptonuria in the Trencin District of Czechoslovakia. Am J Med Genet. 1978;2:159-66. https://doi.org/10.1002/ajmg.1320020207

Cervenansky J, Sitaj S, Urbanek T. Alkaptonuria and ochronosis. J Bone Joint Surg. 1959;41A:1169-82. https://doi.org/10.2106/00004623-195941070-00001

Phornphutkul C, Introne WJ, Perry MB, Bernardini I, Murphey Fitzpatrick DL, et al. Natural history of alkaptonuria. N Engl J Med. 2002;347:2111-21. https://doi.org/10.1056/NEJMoa021736

Femandez-Canon JM, Penalva MA. Molecular characterization of a gene encoding a homogentisate dioxygenase from aspergillus nidulans and identification of its human and plant homologues. J Biol Chem. 1995;36:21199-205. https://doi.org/10.1074/jbc.270.36.21199

Granadino B. Beltran-Valero de Bernabe D, Fernandez-Canon JM, Penalva MA, Rodriguez de Cordoba. The human homogentisate 1,2-dioxygenase (HGO) gene. Genomics. 1997;43:115-22. https://doi.org/10.1006/geno.1997.4805

Keller JM, Macaulay W, Nercessian OA, Jaffe IA. New developments in ochronosis: review of the literature. Rheumatol Int. 2005;25:81-5. https://doi.org/10.1007/s00296-004-0498-1

Ellaway CJ, Holme E, Standing S, Preece MA, Green A, Ploechl E, et al. Outcome of tyrosinemia type III. J Inher Metab Dis. 2001;24:824-32. https://doi.org/10.1023/A:1013936107064

La Du B. Alkaptonuria. En: Royce RM, Steinman B, editores. Connective tissue and its heritable disorders: molecular, genetic and medical aspects. 2.a ed. New York: Wiley-Liss; 2002. p. 809-25. https://doi.org/10.1002/0471221929.ch20

Osler W. Ochronosis: the pigmentation of cartilages, sclerotics and skin in alkaptonuria. Lancet. 1904;1:10-1. https://doi.org/10.1016/S0140-6736(00)97815-2

La Du BN. Alkaptonuria. En: Stanbury JB, editor. The metabolic basis of inherited disease. 3.a ed. New York: McGraw- Hill; 1972. p. 303-7.

Zhao BH, Chen BC, Shao de C, Zhang Q. Osteoarthritis? Ochronotic arthritis! A case study and review of the literature. Knee Surg Sports Traumatol Arthrosc. 2009;17:778-81. https://doi.org/10.1007/s00167-009-0778-0

Wagner LR, Knott JL, Machaffie RA, Walsh JR. Clinical and pathological findings in ochronosis. J Clin Pathol. 1960;13:22-5. https://doi.org/10.1136/jcp.13.1.22

Adonis-Koffy L, Gonzales E, Nathanson S, Spodek C, Bensman A. L'alcaptonurie: une cause rare de coloration anormale des urines. A propos d'un cas chez le nourrison. Arch Pediatr. 2000;7:844-6. https://doi.org/10.1016/S0929-693X(00)80194-3

Castagna A, Giombini A, Vinanti G, Massazza G, Pigozzi F. Arthroscopic treatment of shoulder ochronotic arthropathy: a case report and review of literature. Knee Surg Sports Traumatol Arthrosc. 2006;14(2):176-81. https://doi.org/10.1007/s00167-005-0657-2

Resnick D. Diagnosis of bone and joint disorders. 3.a ed. Philadelphia: WB Saunders; 1995. Vol. 3.

Mestan MA, Bustin GL, Wagner LA. Chiropractic care and ochronotic arthropathy. J Manipulative Physiol Ther. 1999;22(7):473-7. https://doi.org/10.1016/S0161-4754(99)70036-9

Ranganath LR, Cox TF. Natural history of alkaptonuria revisited: analyses based on scoring systems. J Inherit Metab Dis. 2011;34:1141-51. https://doi.org/10.1007/s10545-011-9374-9

Lagier R, Steiger U. Hip arthropathy in ochronosis: anatomical and radiological study. Skeletal Radiol. 1980;5:91-8. https://doi.org/10.1007/BF00347328

Aydogdu S, Cullu E, Ozsoy MH, Sur H. Cementless total knee arthroplasty in ochronotic arthropathy: a case report with 4- year follow-up. J Arthroplasty. 2000;15:539-43. https://doi.org/10.1054/arth.2000.4228

Konttinen Y, Hoikka V, Landtman M, Saari H, Santavirta S, Metsarinne K, et al. Ochronosis: a report of a case and a review of the literature. Clin Exp Rheumatol. 1989;7:435-44.

Findlay GH, Morrison JGL, Simson IW. Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams. Br J Dermatol. 1975;93:613-22. https://doi.org/10.1111/j.1365-2133.1975.tb05110.x

Kutty MK, Lqbal OM, Teh EC. Ochronotic arthropathy: a comparative study of light microscopic and ultrastructural features. Arch Pathol. 1973;96:100-4.

Hunter T, Gordon DA, Ogryzlo MA. The ground pepper sign of synovial fluid: a new diagnostic feature of ochronosis. Rheumatology. 1974;7:45-53.

Thacker M, Garude S, Puri A. Ochronotic arthropathy: arthroscopic findings in the shoulder and the knee. Arthroscopy. 2003;19(8):E14-7. https://doi.org/10.1016/S0749-8063(03)00744-8

Dieppe P, Watt L. Crystal deposition in osteoarthritis. Clin Rheum Dis. 1985;11:367-92. https://doi.org/10.1016/S0307-742X(21)00546-4

Sahin G, Milcan A, Bağiş S, Köktürk A, Pata C, Erdoğan C. A case of ochronosis: upper extremity involvement. Rheumatol Int. 2001;21:78-80. https://doi.org/10.1007/s002960100136

Hamdi N, Cooke TD, Hassan B. Ochronotic arthropathy: case report and review of literature. Int Orthop. 1999;23:122-5. https://doi.org/10.1007/s002640050325

Albers SE, Brozena SJ, Glass LF, Fenske NA. Alkaptonuria and ochronosis: case report and review. J Am Acad Dermatol. 1992;27:609-14. https://doi.org/10.1016/0190-9622(92)70230-D

Mission N, Van Ruyssevelt C, Mullier J. Imaging in alkaptonuria. J Belge Radiol. 1996;79:72-3.

Groseanu L, Marinescu R, Laptoiun D, Botezatu I, Staniceanu F, Zurac S, et al. A late and difficult diagnosis of ochronosis. J Med Life. 2010;3(4):437-43.

Prabhakar S, Bali K, Dhillon MS, Saini R. Rapidly progressive ochronotic destructive hip arthropathy misdiagnosed as tuberculosis. Eur J Orthop Surg Traumatol. 2011;21:357-60. https://doi.org/10.1007/s00590-010-0721-6

Borman P, Bodur H, Ciliz D. Ochronotic arthropathy. Rheumatol Int. 2002;21:205-9. https://doi.org/10.1007/s00296-002-0175-1

Araki K, Sudo A, Hasegawa M, Uchida A. Devastating ochronotic arthropathy with successful bilateral hip and knee arthroplasties. J Clin Rheumatol. 2009;15(3):138-40. https://doi.org/10.1097/RHU.0b013e31819e6b41

Aynaci O, Onder C, Turhan AU. Bilateral hip arthroplasty for ochronotic arthropathy. Clin Rheumatol. 2000;19:150-2. https://doi.org/10.1007/s100670050035

Corra T, Zaccala M, Galante M. Ochronotic arthropathy: rapid destructive hip osteoarthritis associated with metabolic disease. Clin Rheumatol. 1995;14:474-7. https://doi.org/10.1007/BF02207686

Cunningham TJ, Roux E, Lagier R, Fallet GH. Rapidly progressive hip osteoarthrosis-an unusual presentation of ochronosis. Clin Exp Rheumatol. 1989;7:315-8.

Lagier R, Baud CA, Lacotte D, Cunningham T. Rapidly progressive osteoarthrosis of ochronotic origin. A pathologic study. Am J Clin Pathol. 1988;90:95-102. https://doi.org/10.1093/ajcp/90.1.95

Shimizu I, Hamada T, Khalpey Z, Miyanishi K, Hara T. Ochronotic arthropathy: pathological evidence of acute destruction of the hip joint. Clin Rheumatol. 2007;26:1189-91. https://doi.org/10.1007/s10067-006-0326-y

Forslind K, Wollheim FA, Akesson B, Rydholm U. Alkaptonuria and ochronosis in three siblings. Ascorbic acid treatment monitored by urinary HGA excretion. Clin Exp Rheumatol. 1988;6:289-92.

Deeb Z, Frayha R. Multiple vacuum discs, an early sign of ochronosis. Radiologic findings in two brothers. J Rheumatol. 1976;3:82-7.

Millea TP, Segal LS, Liss RG, Stauffer ES. Spine fracture in ochronosis. Report of a case. Clin Orthop. 1992:208-11. https://doi.org/10.1097/00003086-199208000-00035

Farzannia A, Shokouhi G, Hadidchi S. Alkaptonuria and lumbar disc herniation. J Neurosurg (Spine 1). 2003;98:87-9. https://doi.org/10.3171/spi.2003.98.1.0087

Kramer KE, Lopez A, Stefanato CM, Phillips TJ. Exogenous ochronosis. J Am Acad Dermatol. 2000;42:869-71. https://doi.org/10.1016/S0190-9622(00)90257-3

Cullison D, Abele DC, O'Quinn JL. Localized exogenous ochronosis. J Am Acad Dermatol. 1983;8:882-4. https://doi.org/10.1016/S0190-9622(83)80022-X

Wauthy P, Seghers V, Mathonet P, Deuvaert FE. Case report cardiac ochronosis: not so benign. Eur J Cardiothorac Surg. 2009;35:732-3. https://doi.org/10.1016/j.ejcts.2008.12.032

Yoshikai M, Murayama J, Yamada N. Aortic valve regurgitation in alkaptonuria. J Heart Valve Dis. 2004;13(5):863-5.

Gaines J, Pai JR. Cardiovasculer ochronosis. Arch Pathol Lab Med. 1987;111:991-4.

Kovacevic M, Simic O, Medved I, Lucin K, Padovan M. Ochronosis of the aortic valve and aorta. J Heart Valve Dis. 2006;15(5):730-2.

Bal S, Turan Y, Koçyiğit H, Gürgan A, Kurtulmuş S, Güvenç A, Deniz G. Ochronosis with cardiovascular involvement: a case report. Rheumatol Int. 2008;28:479-82. https://doi.org/10.1007/s00296-007-0456-9

Ross R, Glomset JA. The pathogenesis of atherosclerosis. N Engl J Med. 1976;295:369-77. https://doi.org/10.1056/NEJM197608122950707

Butany JW, Naseemuddin A, Moshkowitz Y, Nair V. Ochronosis and aortic valve stenosis. J Card Surg. 2006;21(2):182-4. https://doi.org/10.1111/j.1540-8191.2006.00207.x

Folkes LV, Brull D, Krywawych S, Hayward M, Hughes SE. Aortic stenosis in cardiovascular ochronosis. J Clin Pathol. 2007;60(1):92-3. https://doi.org/10.1136/jcp.2005.032417

Sandler M, Karoum F, Ruthhven C. Parkinsonism with alkaptonuria: A new syndrome? Lancet. 1970;2:76. https://doi.org/10.1016/S0140-6736(70)90240-0

Arras M, Bailey G. Metabolism of DOPA in parkinsonism. N Engl J Med. 1968;278:280. https://doi.org/10.1056/NEJM196802012780517

Siekert R, Gibilisco J. Discoloration of the teeth in alkaptonuria (ochronosis) and parkinsonism. Oral Surg Oral Med Oral Pathol. 1970;29:197-9. https://doi.org/10.1016/0030-4220(70)90081-2

Laskar TH, Sarginson KD. Ochronotic arthropathy- review of four cases. J Bone Joint Surg. 1970;4:653. https://doi.org/10.1302/0301-620X.52B4.653

Kihara T, Yasuda M, Watanabe H, Suenaga Y, Shiokawa S, Wada T, et al. Coexistence of ochronosis and rheumatoid arthritis. Clin Rheumatol. 1994;13:135-8. https://doi.org/10.1007/BF02229885

Simianer S, Krause D, Rau R. Concomitant manifestation of ochronosis and chronic polyarthritis in a patient. Z Rheumatol. 1998;57:50-2. https://doi.org/10.1007/s003930050060

Gemignani G, Olivieri I, Semeria R, Giustarini S, Pasero G. Coexistence of ochronosis and ankylosing spondylitis. J Rheumatol. 1990;17:1707-9.

Weinberger KA. The coexistence of ochronosis and ankylosing spondylitis. J Rheumatol. 1991;18:1948-9.

Roth A, Schmidt K, Muller KM, Haaker R. A case report: ochronosis in combination with chondrocalcinosis. Z Orthop Ihre Grenzgeb. 1999;137:76-8. https://doi.org/10.1055/s-2008-1037040

Cetinus E, Cever I, Kural C, Erturk H, Akyildiz M. Ochronotic arthritis: case reports and review of the literature. Rheumatol Int. 2005;25(6):465-8. https://doi.org/10.1007/s00296-004-0538-x

Morava E, Kosztolanyi G, Engelke UF, Wevers RA. Reversal of clinical symptoms and radiographic abnormalities with protein restriction and ascorbic acid in alkaptonuria. Ann Clin Biochem. 2003;40:108-11. https://doi.org/10.1258/000456303321016268

Cobey MC. Ochronosis (A case report). Clin Orthop. 1972;87:233-4. https://doi.org/10.1097/00003086-197209000-00031

Martin JP, Batkoff B. Homogentisic acid autoxidation and oxygen radical generation: implications for the etiology of alkaptonuric arthritis. Free Radic Biol Med. 1987;3:241-50. https://doi.org/10.1016/S0891-5849(87)80031-X

Tinti L, Spreafico A, Braconi D, Millucci L, Bernardini G, Chellini F, et al. Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model. J Cell Physiol. 2010;225(1):84-91. https://doi.org/10.1002/jcp.22199

Braconi D, Laschi M, Amato L, Bernardini G, Millucci L, Marcolongo R, et al. Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis. Rheumatology. 2010;49:1975-83. https://doi.org/10.1093/rheumatology/keq175

Suwannarat P, O'Brien K, Perry MB, Sebring N, Bernardini I, Kaiser-Kupfer MI, et al. Use of nitisinone in patients with alkaptonuria. Metabolism. 2005;54:719-28. https://doi.org/10.1016/j.metabol.2004.12.017